Evaluation of the Feasibility and Safety of ENCER for Cancer Treatment-Related Fatigue in Patients Receiving Chemotherapy or Radiotherapy

This is a feasibility, double blind, placebo‐controlled clinical study designed toevaluate the effect of 'Encer' on Cancer treatment Related Fatigue.'Encer' is a combination of 5 Homeopathic Medical Product (HMP). The five HMPs areregistered in the Homeopathic Pharmacopeia of the United States and the currentinvestigational treatment 'Encer' is authorized for over‐the‐counter sales in the USA byNDC number.The study aims to test the efficacy of 'Encer' in treating Cancer Treatment‐RelatedFatigue (CTRF) among cancer patients treated with chemotherapy and or radiotherapy usingthe Physiological measurements using Garmin vivosmart 5 and the Functional Assessment ofChronic Illness Therapy ‐Fatigue (FACIT‐F).This feasibility study will include patients that will be randomly assigned to eitherPlacebo or Treatment in 1:1 ratio.